Three dimensional (3D) bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics. Generally, 3D bioprinting utilizes the layer-by-layer method to deposit materials known as bioinks to create tissue-like structures that are later used in medical and tissue engineering fields. Bioprinting covers a broad range of biomaterials.

Currently, bioprinting can be used to print tissues and organs to help research drugs and pills. However, emerging innovations span from bioprinting of cells or extracellular matrix deposited into a 3D gel layer by layer to produce the desired tissue or organ. The recent explosion in popularity of 3D printing is a testament to the promise of this technology and its profound utility in research and regenerative medicine. In addition, 3D bioprinting has begun to incorporate the printing of scaffolds. These scaffolds can be used to regenerate joints and ligaments.

The first patent related to this technology was filed in the United States in 2003 and granted in 2006.

This forum is one of the top-ranked meetings in the field of 3D bioprinting in China. Through participating in it, you can learn more about the processing of technologies, the whole industry and the market of 3D bioprinting in China. Welcome to this academic banquet! Bioon will try our best to provide an excellent platform for you to communicate with China's first-class experts and senior managers, as well as to expand your business in China!